chr1:162741822:G>A Detail (hg19) (DDR2)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr1:162,741,822-162,741,822 |
hg38 | chr1:162,772,032-162,772,032 View the variant detail on this assembly version. |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_006182.2:c.1513G>A | NP_006173.2:p.Gly505Ser |
NM_001014796.1:c.1513G>A | NP_001014796.1:p.Gly505Ser | |
Ensemble | ENST00000367921.8:c.1513G>A | ENST00000367921.8:p.Gly505Ser |
Summary
MGeND
Clinical significance |
![]() |
Variant entry | 2 |
GWAS entry | |
Disease area statistics | Show details |
Frequency
JP | HGVD:[No Data.] |
ToMMo:[No Data.] | |
NCBN:[No Data.] | |
NCBN(Hondo):[No Data.] | |
NCBN(Ryukyu):[No Data.] | |
East asia | ExAC:<0.001 |
Prediction
ClinVar
Clinical Significance |
![]() ![]() |
Review star | ![]() |
Show details |
Disease area statistics
MGeND
Clinical significance | Last evaluated | Condition | Origin | Submission ID | Submitter | Institute | Citation | Comment | Image |
---|---|---|---|---|---|---|---|---|---|
![]() |
ill-defined sites within the digestive system |
![]() |
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan | ||||
![]() |
bronchus or lung, unspecified |
![]() |
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan |
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
2015-09-15 | criteria provided, single submitter | not specified |
![]() |
Detail |
![]() |
2016-03-10 | no assertion provided | Non-small cell lung carcinoma |
![]() |
Detail |
![]() |
2014-12-26 | no assertion criteria provided | Squamous cell lung carcinoma |
![]() |
Detail |
![]() |
2023-12-30 | criteria provided, single submitter | not provided |
![]() |
Detail |
![]() |
2022-11-21 | criteria provided, single submitter | DDR2-related disorder |
![]() |
Detail |
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
lung non-small cell carcinoma | Dasatinib | D |
![]() |
![]() |
Sensitivity/Response | Somatic | 4 | 22328973 | Detail |
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.002 | squamous cell carcinoma | Targeted proteomic profiling of a panel of lung SCC (squamous cell carcinoma) DD... | BeFree | 23822953 | Detail |
<0.001 | squamous cell carcinoma | Targeted proteomic profiling of a panel of lung SCC (squamous cell carcinoma) DD... | BeFree | 23822953 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
In 3T3 fibroblasts expressing the G505S mutation have to be sensitive to the tyrosine kinase inhibit... | CIViC Evidence | Detail |
NM_006182.4(DDR2):c.1513G>A (p.Gly505Ser) AND not specified | ClinVar | Detail |
NM_006182.4(DDR2):c.1513G>A (p.Gly505Ser) AND Non-small cell lung carcinoma | ClinVar | Detail |
NM_006182.4(DDR2):c.1513G>A (p.Gly505Ser) AND Squamous cell lung carcinoma | ClinVar | Detail |
NM_006182.4(DDR2):c.1513G>A (p.Gly505Ser) AND not provided | ClinVar | Detail |
NM_006182.4(DDR2):c.1513G>A (p.Gly505Ser) AND DDR2-related disorder | ClinVar | Detail |
Targeted proteomic profiling of a panel of lung SCC (squamous cell carcinoma) DDR2 mutants demonstra... | DisGeNET | Detail |
Targeted proteomic profiling of a panel of lung SCC (squamous cell carcinoma) DDR2 mutants demonstra... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs115169993 dbSNP
- Genome
- hg19
- Position
- chr1:162,741,822-162,741,822
- Variant Type
- snv
- Reference Allele
- G
- Alternative Allele
- A
- East Asian Chromosome Counts (ExAC)
- 4318
- East Asian Allele Counts (ExAC)
- 0
- East Asian Heterozygous Counts (ExAC)
- 0
- East Asian Homozygous Counts (ExAC)
- 0
- East Asian Allele Frequency (ExAC)
- 0.0
- Chromosome Counts in All Race (ExAC)
- 65596
- Allele Counts in All Race (ExAC)
- 97
- Heterozygous Counts in All Race (ExAC)
- 97
- Homozygous Counts in All Race (ExAC)
- 0
- Allele Frequency in All Race (ExAC)
- 0.0014787487041892798
- Variant (CIViC) (CIViC Variant)
- G505S
- Transcript 1 (CIViC Variant)
- ENST00000367922.3
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/142
- Summary (CIViC Variant)
- Activating mutations in DDR2, including G505S, has been shown to be sensitive to dasatinib in cell lines.
Genome browser